Warning letters, 483s, Recalls, Import Alerts, Audit observations
Five different facilities of Eugia across India and US were inspected by USFDA between December
The Eugia facility in Bhiwadi, Rajasthan, India (FEI 3009883410) was recently classified as OAI (Official
Biocon Visakh (Biocon Biosphere Limited, FEI 30221 25340) was inspected by USFDA investigator Brandy N
Zydus Jarod facility (FEI 3013712903) is classified OAI by USFDA in July 2024. The USFDA
Dr.Reddys Laboratories (DRL) has initiated recall of one lot of Allopurinol Tablets, USP 300mg in
Sagent is recalling two lots of Docetaxel injection in US. The recall follows a customer
Chinese API Manufacturer Sichuan Deebio Pharmaceuticals was awarded USFDA 483 with six observations citing Data
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators
Laurus, Visakh (India) was issued USFDA 483 with five (5) observations following USFDA inspection by
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators
